Baidu
map

Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1

Wei, H; Liu, XO; Wang, Y; Lin, D; Zhou, CL; Liu, BC; Qiu, SW; Gu, RX; Li, Y; Wei, SN; Gong, BF; Liu, KQ; Gong, XY; Liu, YT; Zhang, GJ; Fang, QY; Zhang, JP; Jin, JJ; Ma, YS; Mi, YC; Wang, JX

Wang, JX (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis,Leukemia Ctr, Nanjing Rd 288, Tianjin 300020, Peoples R China.

EXPERIMENTAL HEMATOLOGY, 2021; 96 (): 63

Abstract

Minimal residual disease (MRD) levels monitored by polymerase chain reaction are associated with outcomes in acute myeloid leukemia with RUNX1-RUNX1T1......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map